Open Texas Cancer-Research Recruitment Funding
The Cancer Prevention and Research Institute of Texas (CPRIT) is accepting FY 2027 applications for Recruitment of Established Investigators (RFA R-27.1-REI). The mechanism helps Texas academic institutions recruit outstanding senior research faculty with distinguished careers and established cancer-research programs.
Funding
Current CPRIT guidance lists an award of up to $4,000,000 over a maximum five-year period. CPRIT’s FY27 instructions also identify a lower $2,000,000 threshold for emerging research institutions seeking separate consideration under the recruitment framework.
Who Can Nominate
Nominations are submitted on behalf of a specific investigator by the president, provost, vice president for research, or appropriate dean of a Texas-based public or private institution of higher education, including academic health institutions. The nominator starts and completes the application workflow, and the institution’s Authorized Signing Official submits the final application.
Current Review-Cycle Timing
The overall FY27 recruitment receipt period runs from June 23, 2026 through June 21, 2027, subject to available funding. CPRIT reviews recruitment applications in recurring cycles. For the cycle currently open in September 2026, applications are due October 20, 2026 at 11:59 PM Central Time. CPRIT states that the deadline will not be extended. If the 20th falls on a weekend in later cycles, the deadline moves to the following Monday as shown in the official FY27 schedule.
Submission Controls
Recruitment applications are currently submitted through CPRIT’s recruitment application system. The investigator prepares the scientific and supporting material; the nominator completes the institutional sections; and the Authorized Signing Official performs final submission. CPRIT requires uploaded application documents to be PDFs and provides mechanism-specific templates and formatting rules.
Atlas Fit Analysis
Atlas Opportunity Score: 92/100. This is a high-value, multi-year Texas cancer-research workforce and institutional-capacity opportunity with continuous review cycles, but it is only relevant when a Texas academic institution has a legitimate senior-investigator recruitment underway.
N9+ Direct Vendor Fit: 0/100. This is faculty-recruitment funding rather than a clinical-technology procurement. Atlas should not manufacture a device or telehealth use case.
QC Healthcare Fit: 0/100. The mechanism supports recruitment of cancer researchers, not general clinical staffing coverage.
Required Next Action
Identify a qualifying senior cancer investigator and institutional nominator, confirm the recruitment can satisfy CPRIT’s current RFA and FY27 instructions, organize the investigator and institutional documents, route the package through the nominator and Authorized Signing Official, and submit for the current cycle by October 20, 2026 at 11:59 PM CT. If that cycle is missed, confirm that funding remains available and use the next published CPRIT recruitment cycle rather than assuming the overall June 21, 2027 endpoint guarantees funding.
Official sources: CPRIT Funding Opportunities and FY 2027 Recruitment Instructions for Applicants.